...
snoa-img

Sonoma Pharmaceuticals Inc, Common Stock

SNOA

NAQ

$2.73

+$0.05

(1.87%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$3.59M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
0
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.38
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.44 L
$9.37 H
$2.73

About Sonoma Pharmaceuticals Inc, Common Stock

Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye and nasal care, oral care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. The company offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peeling, and eczema/atopic dermatitis; Gramaderm for the treatment of topical mild to moderate acne; Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription and over-the-counter product used to relieve skin irritations, lacerations, abrasions, and burns; Celacyn, a scar management gel; SebuDerm to manage and relieve the burning, itching, erythema, scaling, and pain associated with seborrhea and seborrheic dermatitis; and Pediacyn, an atopic dermatitis hydrogel. It also provides Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a range of pathogens; Ocucyn eyelid and eyelash cleanser; Ocudox for eye care; Sinudox for nasal irrigation; Microdacyn60 oral care solution to treat mouth and throat infections; and Podiacyn, a foot care product. In addition, the company offers MicrocynAH, an HOCl-based solution used to relieve common symptoms of hot spots, scratches, skin rashes post-surgical sites, and irritated animal skin; MicrocynVS, an animal care product; Nanocyn, a hospital-grade disinfectant; Acuicyn, an antimicrobial prescription solution for the treatment of blepharitis and the daily hygiene of eyelids and lashes; MucoClyns for use in emergencies and on mucous membranes, cuts, abrasions, burns, and body surfaces; and Endocyn root canal irrigation solutions. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Boulder, Colorado. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameSNOASectorS&P500
1-Week Return5.41%-0.33%-1.49%
1-Month Return-6.83%-4.57%-0.37%
3-Month Return-17.52%-9.96%3.89%
6-Month Return-28.08%-5.67%9.34%
1-Year Return-31.92%2.53%25.19%
3-Year Return-97.16%-1.43%24.7%
5-Year Return-96.75%34.73%85.39%
10-Year Return-99.8%102.14%187.19%

Financials

Mar '20Mar '21Mar '22Mar '23Mar '245YR TREND
Total Revenue18.94M18.63M12.63M13.27M12.73M[{"date":"2020-03-31","value":100,"profit":true},{"date":"2021-03-31","value":98.38,"profit":true},{"date":"2022-03-31","value":66.69,"profit":true},{"date":"2023-03-31","value":70.09,"profit":true},{"date":"2024-03-31","value":67.25,"profit":true}]
Cost of Revenue10.60M12.07M8.63M8.79M7.99M[{"date":"2020-03-31","value":87.85,"profit":true},{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":71.54,"profit":true},{"date":"2023-03-31","value":72.87,"profit":true},{"date":"2024-03-31","value":66.2,"profit":true}]
Gross Profit8.33M6.56M3.99M4.48M4.75M[{"date":"2020-03-31","value":100,"profit":true},{"date":"2021-03-31","value":78.71,"profit":true},{"date":"2022-03-31","value":47.92,"profit":true},{"date":"2023-03-31","value":53.73,"profit":true},{"date":"2024-03-31","value":56.94,"profit":true}]
Gross Margin44.01%35.21%31.62%33.73%37.26%[{"date":"2020-03-31","value":100,"profit":true},{"date":"2021-03-31","value":80.01,"profit":true},{"date":"2022-03-31","value":71.85,"profit":true},{"date":"2023-03-31","value":76.65,"profit":true},{"date":"2024-03-31","value":84.67,"profit":true}]
Operating Expenses15.00M10.01M9.88M9.05M9.45M[{"date":"2020-03-31","value":100,"profit":true},{"date":"2021-03-31","value":66.7,"profit":true},{"date":"2022-03-31","value":65.85,"profit":true},{"date":"2023-03-31","value":60.3,"profit":true},{"date":"2024-03-31","value":62.96,"profit":true}]
Operating Income(6.67M)(3.45M)(5.89M)(4.57M)(4.70M)[{"date":"2020-03-31","value":-667100000,"profit":false},{"date":"2021-03-31","value":-344900000,"profit":false},{"date":"2022-03-31","value":-588700000,"profit":false},{"date":"2023-03-31","value":-457000000,"profit":false},{"date":"2024-03-31","value":-470100000,"profit":false}]
Total Non-Operating Income/Expense3.88M(449.00K)459.00K(598.00K)-[{"date":"2020-03-31","value":100,"profit":true},{"date":"2021-03-31","value":-11.57,"profit":false},{"date":"2022-03-31","value":11.83,"profit":true},{"date":"2023-03-31","value":-15.41,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]
Pre-Tax Income(2.83M)(3.90M)(5.42M)(5.18M)(5.03M)[{"date":"2020-03-31","value":-282500000,"profit":false},{"date":"2021-03-31","value":-390200000,"profit":false},{"date":"2022-03-31","value":-541800000,"profit":false},{"date":"2023-03-31","value":-518400000,"profit":false},{"date":"2024-03-31","value":-503100000,"profit":false}]
Income Taxes121.00K713.00K(332.00K)(33.00K)(196.00K)[{"date":"2020-03-31","value":16.97,"profit":true},{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":-46.56,"profit":false},{"date":"2023-03-31","value":-4.63,"profit":false},{"date":"2024-03-31","value":-27.49,"profit":false}]
Income After Taxes(2.95M)(4.62M)(5.09M)(5.15M)-[{"date":"2020-03-31","value":-294600000,"profit":false},{"date":"2021-03-31","value":-461500000,"profit":false},{"date":"2022-03-31","value":-508600000,"profit":false},{"date":"2023-03-31","value":-515100000,"profit":false},{"date":"2024-03-31","value":"-","profit":true}]
Income From Continuous Operations(2.95M)(4.62M)(5.09M)(5.15M)(4.83M)[{"date":"2020-03-31","value":-294600000,"profit":false},{"date":"2021-03-31","value":-461500000,"profit":false},{"date":"2022-03-31","value":-508600000,"profit":false},{"date":"2023-03-31","value":-515100000,"profit":false},{"date":"2024-03-31","value":-483500000,"profit":false}]
Income From Discontinued Operations665.00K665.00K---[{"date":"2020-03-31","value":100,"profit":true},{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}]
Net Income(2.95M)(4.62M)(5.09M)(5.15M)(4.83M)[{"date":"2020-03-31","value":-294600000,"profit":false},{"date":"2021-03-31","value":-461500000,"profit":false},{"date":"2022-03-31","value":-508600000,"profit":false},{"date":"2023-03-31","value":-515100000,"profit":false},{"date":"2024-03-31","value":-483500000,"profit":false}]
EPS (Diluted)11.96(0.24)-(2.42)(0.72)[{"date":"2020-03-31","value":100,"profit":true},{"date":"2021-03-31","value":-2.04,"profit":false},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":-20.23,"profit":false},{"date":"2024-03-31","value":-6.01,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

SNOA
Cash Ratio 1.23
Current Ratio 3.69
Quick Ratio 2.84

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

SNOA
ROA (LTM) -19.59%
ROE (LTM) -74.65%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

SNOA
Debt Ratio Lower is generally better. Negative is bad. 0.61
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.39

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

SNOA
Trailing PE NM
Forward PE NM
P/S (TTM) 0.29
P/B 0.68
Price/FCF 11
EV/R 0.14
EV/Ebitda NM
PEG NM

FAQs

What is Sonoma Pharmaceuticals Inc share price today?

Sonoma Pharmaceuticals Inc (SNOA) share price today is $2.73

Can Indians buy Sonoma Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Sonoma Pharmaceuticals Inc (SNOA) on Vested. To buy Sonoma Pharmaceuticals Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SNOA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Sonoma Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Sonoma Pharmaceuticals Inc (SNOA) via the Vested app. You can start investing in Sonoma Pharmaceuticals Inc (SNOA) with a minimum investment of $1.

How to invest in Sonoma Pharmaceuticals Inc shares from India?

You can invest in shares of Sonoma Pharmaceuticals Inc (SNOA) via Vested in three simple steps:

  • Click on Sign Up or Invest in SNOA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Sonoma Pharmaceuticals Inc shares
What is Sonoma Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Sonoma Pharmaceuticals Inc (SNOA) is $9.37. The 52-week low price of Sonoma Pharmaceuticals Inc (SNOA) is $2.44.

What is Sonoma Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Sonoma Pharmaceuticals Inc (SNOA) is

What is Sonoma Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Sonoma Pharmaceuticals Inc (SNOA) is 0.68

What is Sonoma Pharmaceuticals Inc dividend yield?

The dividend yield of Sonoma Pharmaceuticals Inc (SNOA) is 0.00%

What is the Market Cap of Sonoma Pharmaceuticals Inc?

The market capitalization of Sonoma Pharmaceuticals Inc (SNOA) is $3.59M

What is Sonoma Pharmaceuticals Inc’s stock symbol?

The stock symbol (or ticker) of Sonoma Pharmaceuticals Inc is SNOA

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top